Q1: 2026-05-14 Earnings Summary
EPS of $0.18 beats by $0.05
| Revenue of $647.92M (15.86% Y/Y) beats by $34.68M
Aveanna Healthcare Holdings Inc. (AVAH) Q1 2026 Earnings Call May 14, 2026 10:00 AM EDT
Company Participants
Debbie Stewart – Senior VP & Principal Accounting Officer
Jeffrey Shaner – President, CEO & Director
Matt Buckhalter – CFO & Principal Financial Officer
Conference Call Participants
Benjamin Hendrix – RBC Capital Markets, Research Division
Brian Tanquilut – Jefferies LLC, Research Division
Raj Kumar – Stephens Inc., Research Division
Benjamin Rossi – JPMorgan Chase & Co, Research Division
Sean Dodge – BMO Capital Markets Equity Research
John Ransom – Raymond James & Associates, Inc., Research Division
Andrew Mok – Barclays Bank PLC, Research Division
Pito Chickering – Deutsche Bank AG, Research Division
Albert Rice – UBS Investment Bank, Research Division
Jared Haase – William Blair & Company L.L.C., Research Division
Grayson Joshua McAlister – Truist Securities, Inc., Research Division
Presentation
Operator
Good morning, and welcome to Aveanna Healthcare Holdings, Inc. First Quarter 2026 Earnings Call. Today’s call is being recorded, and we have allocated 1 hour for prepared remarks and Q&A.
At this time, I’d like to turn the call over to Debbie Stewart, Aveanna’s Chief Accounting Officer. Thank you. You may begin.
Debbie Stewart
Senior VP & Principal Accounting Officer
Good morning, and welcome to Aveanna’s First Quarter 2026 Earnings Call. I am Debbie Stewart, the company’s Chief Accounting Officer. With me today is Jeff Shaner, our Chief Executive Officer; and Matt Buckhalter, our Chief Financial Officer.
During this call, we will make forward-looking statements. Risk factors that may impact those statements and could cause actual future results to differ materially from currently projected results are described in this morning’s press release and the reports we file with the SEC. The company does not undertake any duty to update such forward-looking statements.
Additionally, during today’s call, we will discuss certain non-GAAP measures, which we believe can be useful in evaluating our performance. The presentation of this
